From June 16 to 19, 2025, the annual flagship event of the global biotechnology industry—the BIO International Convention—kicked off grandly in Boston. As the world's most influential industry gathering, this year's BIO attracted over 20,000 industry leaders, scientific experts, and representatives from innovative companies worldwide to collectively map out the…

The global biomanufacturing capacity gap and budget constraints have ignited the “The Fourth Revolutionary Wave of Biologics Manufacturing”, with production sites expanding towards million-liter scales. In this context, Contract Development and Manufacturing Organizations (CDMOs) have become key players in global biomanufacturing. Initially, from 1980 to 2000, manufacturing relied on self-built systems…

On March 28, 2024, as the final drop of product was successfully harvested, BiBo achieved an industry marvel—"Right on the First Time, Success on the First Time" in process scale-up production on its newly operational 30,000-liter production platform! This milestone not only marks the official industrialization of the world's fourth-generation…

Forbes China officially announced the 2025 Forbes China Pioneer Innovators in Industry Development list, with Jiao Peng, Chairman and CEO of Bibo Pharma, securing a distinguished position for his exceptional contributions to the CDMO (Contract Development and Manufacturing Organization) selection. Dr. Jiao Peng said after winning the award, "I feel…

On March 12, 2025, BiBo Pharma was honored with the "Emerging CDMO of the Year" award at the Asia-Pacific Biopharma Excellence Awards (ABEA) ceremony hosted by IMAPAC. Asia-Pacific Biopharma Excellence Awards: A Benchmark for Industry Innovation The Asia-Pacific Biopharma Excellence Awards (ABEA) seeks to give recognition to exceptional bioprocessing experts,…

In early March, Bibo successfully completed its first 30,000-liter mammalian cell (CHO) production task in 2025 This production task coincided with Chinese New Year holiday. Guided by customer needs, the Bibo team remained dedicated on the production front, employing scientific scheduling and meticulous management to ensure an uninterrupted production process.…

The high cost of biologics is one of the biggest barriers to global healthcare access. Today, biologic therapies are largely confined to developed countries with a GDP per capita of $12,000 or more—leaving billions without access. But what if we could change that? Join us on February 18, 2025, as…

At 2pm on November 11, 2022, with the sudden appearance of a rainbow in the sky, the world's first 30,000-liter stainless steel mammalian cell bioreactor was unveiled in Lingang, Shanghai. This is the core equipment of BIBO Pharma's large-scale CDMO comprehensive platform project for biopharmaceuticals located in Lingang, Shanghai (referred…

In September 2022, Shanghai TopAlliance Biomedical Technology Co., Ltd. (referred as "TopAlliance") and Shanghai BiBo Biomedical Engineering Co., Ltd. (referred as "BiBo Pharma") signed a strategic cooperation agreement in Shanghai. According to the agreement, the two parties will carry out in-depth cooperation in biotech drug technology development and commercial production based on their…

On October 22, 2022, after nearly 10 months of careful preparation and unremitting efforts, the P02 production site of BiBo Pharma which located in Lingang Blue Bay has successfully completed the EU QP on-site audit. The audit has no serious defects (Critical, 0) and no major defects (Major, 0). The…

On August 18, 2021, the construction of Shanghai BiBo Biopharmaceuticals large-scale CDMO integrated platform phase II (P03) project has been officially started, and held a groundbreaking ceremony in the new Lingang area of China (Shanghai) Pilot Free Trade Zone. This represented the construction of the world's first 30,000-liter large-scale mammalian…

After 147 days of efforts by all staffs of Shanghai BiBo, on May 20, 2021, Shanghai BiBo Biopharmaceuticals large-scale CDMO integrated production platform Lingang Phase I (P02), was officially handed over from BiBo Engineering Department to Manufacture Department, marking the verification and commissioning stage of the very few among the…